Add BrightSurf on Google Email

To study treatment resistance in high-grade serous ovarian cancer, MSK researchers develop new approach

MSK researchers have developed a new method to study treatment resistance in high-grade serous ovarian cancer. By analyzing blood samples from 18 patients, they identified subpopulations of cancer cells with distinctive genetic features that contribute to recurrence. This approach may help develop targeted treatments for specific vulne...

Crosstalk among aging, circadian rhythms, and cancers

Research highlights the interconnected relationship between aging, circadian rhythms, and cancer, with shared mechanisms including genomic instability, cellular senescence, and chronic inflammation. Modulating circadian rhythms may serve as a novel strategy to intervene in age-related functional decline and treat cancer.

SourceResearch·JournalResearch·TypeNews article·DateMar 11, 2025

Chromosome copying errors pinpointed in embryo development

Researchers at RIKEN Center for Biosystems Dynamics found multiple specialized types of DNA replication in early-stage embryos, including a period of instability prone to chromosomal copying errors. This discovery could lead to improved methods of in vitro fertilization (IVF) and better strategies for minimizing chromosomal abnormalities.

SourceRIKEN·JournalNature·DateAug 28, 2024

Dogma-challenging telomere findings may offer new insights for cancer treatments

A new study found that PARP1 is involved in the repair of telomeres, which can lead to genomic instability and cancer. Impairing this process can lead to telomere shortening and increased risk of cancer. The findings challenge existing dogma and open up new possibilities for improving cancer therapies.

SourceUniversity of Pittsburgh·JournalNature Structural & Molecular Biology·TypeExperimental study·DateMay 7, 2024

Massive study identifies new biomarkers for renal cancer subtypes, improving diagnosis and—eventually—treatment

A massive study identifies new biomarkers for renal cell carcinoma subtypes, improving diagnosis and treatment. The researchers' integrative analysis of proteogenomic datasets reveals molecular features shared by clear cell and non-clear cell RCC tumors, as well as unique features to various subtypes.

SourceMichigan Medicine - University of Michigan·JournalCell Reports Medicine·TypeExperimental study·DateMay 6, 2024

New understanding of why kidney cancers become metastatic discovered by MD Anderson researchers

Researchers at MD Anderson Cancer Center have engineered a new model of aggressive renal cell carcinoma, highlighting molecular targets and genomic events that trigger chromosomal instability. The loss of interferon receptor genes plays a pivotal role in allowing cancer cells to become tolerant of chromosomal instability.

HKU biologists reveal a molecular scissor that cuts chromatin bridge and prevents DNA damages and autoimmunity

A research team led by Dr Gary Ying Wai Chan reveals the function of enzyme ANKLE1 in cutting chromatin bridges, preventing DNA damages and autoimmunity. This discovery has significant implications for understanding immune responses and developing new strategies to prevent diseases such as cancer and autoinflammatory disorders.

SourceThe University of Hong Kong·JournalAdvanced Science·TypeExperimental study·DateApr 20, 2023

The guardian of the (epi-)genome

A research team led by Ivano Amelio found that the protein p53 acts as a key to maintaining genomic stability, preventing cancer-promoting mutations. Without p53, cells become more aggressive and prone to acquire genomic instability.

SourceUniversity of Konstanz·JournalCell Reports·DateNov 2, 2022

Tumor ‘signatures’ could provide key to more accurate treatment for deadliest cancers

Researchers have developed a framework to analyze chromosomal instability in human cancers, characterizing 17 different types of signatures. These signatures can predict how tumors respond to drugs and help identify future drug targets. The discovery aims to improve survival rates for millions of cancer patients worldwide.

SourceUniversity of Cambridge·JournalNature·TypeData/statistical analysis·DateJun 15, 2022

Researchers create a fly to study how a normal cell turns cancerous

Scientists at IRB Barcelona created a Drosophila melanogaster fly model that reproduces the steps of healthy cell transformation into cancer. The model can help identify genes and molecules involved in cancer progression, potentially leading to specific treatments for cells with genomic instability.

SourceInstitute for Research in Biomedicine (IRB Barcelona)·JournalProceedings of the National Academy of Sciences·DateNov 29, 2012

Fruit fly's genome sequence finished in record time: Physical maps are the key to accuracy

The Drosophila melanogaster fruit fly genome has been sequenced in full, with a focus on physical maps to ensure accuracy. The completion of the genome sequence is significant, as it reveals connections between fruit fly and human genes, offering insights into diseases such as cancer, kidney disease, and metabolic disorders.